INO
Inovio Pharmaceuticals Inc
1.20$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | 100.0% | – | 100.0% | 100.0% | – | – | – | – | – | – | |
| 265.9% | 170.7% | – | 822.4% | – | 663.1% | – | – | – | – | – | – | – | |
| 100.0% | -70.7% | – | -722.4% | – | -563.1% | 100.0% | – | – | – | – | – | – | |
| 3,991.0% | 16,807.5% | – | 22,916.4% | – | 11,013.8% | 24,625,288.1% | – | – | – | – | – | – | |
| 2,555.1% | 9,978.8% | – | 10,129,499.2% | – | 6,497.0% | 13,811,686.0% | – | – | – | – | – | – | |
| 9,252.6% | 26,615.6% | – | 32,223.5% | – | 16,847.6% | 38,436,974.1% | – | – | – | – | – | – | |
| -9,152.6% | -26,686.3% | – | -32,945.9% | – | -17,410.8% | -38,337.0% | – | – | – | – | – | – | |
| 80.7% | 275.0% | – | 0.0% | – | 0.0% | 0.0% | – | – | – | – | – | – | |
| -8,734.8% | -24,357.9% | – | -31,993.3% | – | -16,566.4% | -30,140.5% | – | – | – | – | – | – | |
| -265.9% | 0.0% | – | 0.0% | – | -612.4% | – | – | – | – | – | – | – | |
| -8,734.8% | -24,357.9% | – | -31,993.3% | – | -16,566.4% | -30,140.5% | – | – | – | – | – | – | |
| -8,388.2% | -23,912.2% | – | -31,170.9% | – | -15,903.3% | -38,336,974.1% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.